CASI Pharmaceuticals (CASI) Short Interest Ratio & Short Volume $1.26 -0.03 (-2.33%) Closing price 03:59 PM EasternExtended Trading$1.27 +0.01 (+0.48%) As of 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CASI Pharmaceuticals Short Interest DataCASI Pharmaceuticals (CASI) has a short interest of 30,300 shares, representing 0.77% of the float (the number of shares available for trading by the public). This marks a 131.30% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 48,073 shares to cover all short positions.Current Short Interest30,300 sharesPrevious Short Interest13,100 sharesChange Vs. Previous Month+131.30%Dollar Volume Sold Short$35.75 thousandShort Interest Ratio0.3 Days to CoverLast Record DateJune 30, 2025Outstanding Shares12,300,000 sharesFloat Size3,920,000 sharesShort Percent of Float0.77%Today's Trading Volume15,904 sharesAverage Trading Volume48,073 sharesToday's Volume Vs. Average33% Short Selling CASI Pharmaceuticals? Sign up to receive the latest short interest report for CASI Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCASI Short Interest Over TimeCASI Days to Cover Over TimeCASI Percentage of Float Shorted Over Time CASI Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202530,300 shares $35.75 thousand +131.3%0.8%0.3 $1.18 6/15/202513,100 shares $24.10 thousand -35.8%0.3%0.1 $1.84 5/31/202520,400 shares $38.96 thousand +20.7%0.5%2.1 $1.91 5/15/202516,900 shares $30.59 thousand +62.5%0.3%1.8 $1.81 4/30/202510,400 shares $20.18 thousand -46.9%0.2%1.1 $1.94 4/15/202519,600 shares $38.04 thousand +2.6%0.4%1.6 $1.94 3/31/202519,100 shares $41.26 thousand -18.0%0.4%1.3 $2.16 3/15/202523,300 shares $51.35 thousand -15.0%0.5%1.1 $2.20 2/28/202527,400 shares $61.65 thousand -24.1%0.6%0.9 $2.25 2/15/202536,100 shares $90.25 thousand -2.7%0.8%1 $2.50 Get the Latest News and Ratings for CASI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CASI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202537,100 shares $91.64 thousand +17.0%0.8%1 $2.47 1/15/202531,700 shares $80.52 thousand -48.0%0.8%0.7 $2.54 12/31/202461,000 shares $172.63 thousand +43.5%1.6%1.3 $2.83 12/15/202442,500 shares $132.18 thousand -4.9%1.1%1 $3.11 11/30/202444,700 shares $169.86 thousand -0.5%1.2%1.2 $3.80 11/15/202444,900 shares $239.32 thousand -40.6%1.2%1.5 $5.33 10/31/202475,600 shares $452.84 thousand -31.3%1.9%2.8 $5.99 10/15/2024110,000 shares $613.80 thousand -24.9%2.6%4.1 $5.58 9/30/2024146,500 shares $873.14 thousand -9.4%3.4%4.3 $5.96 9/15/2024161,700 shares $1.16 million -2.9%3.8%0.7 $7.17 8/31/2024166,600 shares $1.10 million -3.1%3.9%0.7 $6.59 8/15/2024172,000 shares $1.13 million -15.1%4.0%0.7 $6.56 7/31/2024202,600 shares $1.47 million -6.9%3.2%0.8 $7.25 7/15/2024217,600 shares $1.36 million -58.9%3.4%0.9 $6.25 6/30/2024529,600 shares $2.91 million +771.1%8.2%2.3 $5.50 6/15/202460,800 shares $189.09 thousand -23.7%0.9%1.1 $3.11 5/31/202479,700 shares $307.96 thousand +50.1%1.3%2 $3.86 5/15/202453,100 shares $180.01 thousand +14.7%0.8%0.3 $3.39 4/30/202446,300 shares $106.49 thousand -25.9%0.7%0.2 $2.30 4/15/202462,500 shares $153.13 thousand -24.0%1.0%0.3 $2.45 3/31/202482,200 shares $296.74 thousand -35.4%1.3%0.4 $3.61 3/15/2024127,300 shares $404.81 thousand +204.6%2.2%0.7 $3.18 2/29/202441,800 shares $233.66 thousand -21.3%0.7%0.2 $5.59 2/15/202453,100 shares $323.38 thousand +0.8%0.9%1.1 $6.09 1/31/202452,700 shares $361.52 thousand +10.0%0.9%1 $6.86 1/15/202447,900 shares $291.23 thousand +74.8%0.8%0.9 $6.08 12/31/202327,400 shares $196.18 thousand -18.7%0.5%0.5 $7.16 12/15/202333,700 shares $206.58 thousand -58.4%0.6%0.6 $6.13 11/30/202381,000 shares $452.79 thousand -46.4%1.4%1.9 $5.59 11/15/2023151,200 shares $657.72 thousand -33.0%2.5%4.9 $4.35Critical AI announcement set to ignite AI 2.0 (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 10/31/2023225,700 shares $911.83 thousand +0.6%3.4%9 $4.04 10/15/2023224,400 shares $587.93 thousand -2.6%3.4%12 $2.62 9/30/2023230,400 shares $589.82 thousand -1.5%3.5%15.8 $2.56 9/15/2023233,900 shares $493.53 thousand -1.6%3.5%22.1 $2.11 8/31/2023237,600 shares $548.86 thousand -1.4%3.6%9.1 $2.31 8/15/2023241,000 shares $535.02 thousand +2.4%3.6%8.1 $2.22 7/31/2023235,300 shares $571.78 thousand -3.6%3.5%7.7 $2.43 7/15/2023244,100 shares $646.87 thousand -2.6%3.7%8.2 $2.65 6/30/2023250,700 shares $624.24 thousand -7.4%3.8%6.9 $2.49 6/15/2023270,800 shares $557.85 thousand +12.6%4.1%5.2 $2.06 5/31/2023240,500 shares $678.21 thousand -5.1%3.4%6.5 $2.82 5/15/2023253,300 shares $640.65 thousand -0.7%3.6%7.3 $2.53 4/30/2023255,200 shares $730.38 thousand -5.0%3.6%7.3 $2.86 4/15/2023268,700 shares $964.63 thousand +6.5%3.6%7.1 $3.59 3/31/2023252,200 shares $585.10 thousand +3.4%2.7%6.4 $2.32 3/15/2023244,000 shares $417.24 thousand -6.1%2.6%9.1 $1.71 2/28/2023259,700 shares $501.22 thousand -1.7%2.8%8.3 $1.93 2/15/2023264,300 shares $509.78 thousand +0.9%2.2%8 $1.93 1/31/2023262,000 shares $534.48 thousand -5.7%2.0%7.8 $2.04 1/15/2023277,800 shares $548.66 thousand -5.9%2.1%8.2 $1.98 12/30/2022295,200 shares $528.41 thousand +44.1%2.3%8.7 $1.79 12/15/2022204,900 shares $370.87 thousand +77.6%1.6%5.5 $1.81 11/30/2022115,400 shares $229.65 thousand +27.4%0.9%2.6 $1.99 11/15/202290,600 shares $176.67 thousand -13.6%0.7%1.6 $1.95 10/31/2022104,900 shares $206.65 thousand -9.6%1.0%0.6 $1.97 10/15/2022116,000 shares $257.52 thousand +26.2%1.1%0.6 $2.22 9/30/202291,900 shares $238.94 thousand -41.5%0.9%0.4 $2.60 9/15/2022157,200 shares $664.96 thousand +28.9%1.5%0.7 $4.23 8/31/2022122,000 shares $457.50 thousand -57.1%1.2%0.6 $3.75 8/15/2022284,500 shares $1.14 million +94.5%2.7%1.3 $4.02 7/31/2022146,300 shares $361.36 thousand -18.8%1.4%1.5 $2.47 7/15/2022180,100 shares $491.67 thousand -14.9%1.7%2.5 $2.73 6/30/2022211,700 shares $605.46 thousand +28.9%2.0%3.1 $2.86 6/15/2022164,300 shares $509.33 thousand +89.9%1.8%2.4 $3.10 5/31/202286,500 shares $297.56 thousand -85.9%N/A1.4 $3.44 5/15/2022612,700 shares $213.53 thousand +2.1%0.7%1.8 $0.35 4/30/2022600,200 shares $258.09 thousand -5.2%0.7%1.5 $0.43 4/15/2022633,400 shares $393.34 thousand -26.7%0.7%1.3 $0.62 3/31/2022863,900 shares $699.50 thousand -10.8%1.0%1.4 $0.81 3/15/2022968,800 shares $773.97 thousand -19.3%1.1%1.5 $0.80 2/28/20221,200,000 shares $1.01 million -4.0%1.4%1.6 $0.84 2/15/20221,250,000 shares $1.02 million -22.4%1.4%1.4 $0.82 1/31/20221,610,000 shares $1.08 million +1.9%1.8%1.4 $0.67 1/15/20221,580,000 shares $1.14 million -25.8%N/A1.3 $0.72 12/31/20212,130,000 shares $1.70 million -9.4%2.4%1.7 $0.80 12/15/20212,350,000 shares $1.89 million -27.5%2.7%1.6 $0.80 11/30/20213,240,000 shares $2.90 million +14.5%3.7%1.4 $0.90 11/15/20212,830,000 shares $2.89 million -8.7%3.2%1.2 $1.02 10/29/20213,100,000 shares $3.35 million +12.3%3.5%1.2 $1.08 10/15/20212,760,000 shares $3.17 million +11.7%3.1%1.1 $1.15Critical AI announcement set to ignite AI 2.0 (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 9/30/20212,470,000 shares $2.94 million -10.5%2.8%1.1 $1.19 9/15/20212,760,000 shares $4.08 million -34.1%3.1%1.3 $1.48 8/31/20214,190,000 shares $6.70 million +28.9%4.7%3.1 $1.60 8/13/20213,250,000 shares $4.26 million +5.5%3.7%2.6 $1.31 7/30/20213,080,000 shares $3.57 million -2.2%3.5%3.4 $1.16 7/15/20213,150,000 shares $4.22 million -2.8%3.5%2.3 $1.34 6/30/20213,240,000 shares $5.02 million -40.1%3.6%2.2 $1.55 6/15/20215,410,000 shares $8.93 million +1.5%6.1%2.6 $1.65 5/28/20215,330,000 shares $8.53 million +24.0%6.0%2.7 $1.60 5/14/20214,300,000 shares $6.11 million +24.3%4.8%2.3 $1.42 4/30/20213,460,000 shares $6.26 million +52.4%3.9%1.9 $1.81 4/15/20212,270,000 shares $4.27 million +8.6%2.7%1.6 $1.88 3/31/20212,090,000 shares $4.16 million +22.9%2.7%1.7 $1.99 3/15/20211,700,000 shares $4.22 million -3.4%2.3%3.3 $2.48 2/26/20211,760,000 shares $4.38 million +6.7%2.4%3.7 $2.49 2/12/20211,650,000 shares $4.95 million -9.8%2.3%3.2 $3.00 1/29/20211,830,000 shares $6.28 million +2.2%2.5%3.9 $3.43 1/15/20211,790,000 shares $5.96 million -3.2%2.5%3.3 $3.33 12/31/20201,850,000 shares $5.48 million -2.1%2.6%4 $2.96 12/15/20201,890,000 shares $4.59 million +1.6%2.6%4.4 $2.43 11/30/20201,860,000 shares $4.50 million +1.1%2.6%4.7 $2.42 11/15/20201,840,000 shares $3.64 million +4.0%2.5%4.8 $1.98 10/30/20201,770,000 shares $3.42 million +22.1%2.4%4.4 $1.93 10/15/20201,450,000 shares $2.48 million -6.5%2.0%3.4 $1.71 9/30/20201,550,000 shares $2.37 million +0.7%2.1%3.1 $1.53 9/15/20201,540,000 shares $2.62 million +19.4%2.1%3.1 $1.70 8/31/20201,290,000 shares $2.21 million -9.8%1.8%2.8 $1.71 8/14/20201,430,000 shares $2.75 million -21.4%2.3%3.3 $1.92 7/31/20201,820,000 shares $3.51 million +9.6%3.8%4.2 $1.93 CASI Short Interest - Frequently Asked Questions What is CASI Pharmaceuticals' current short interest? Short interest is the volume of CASI Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 30,300 shares of CASI short. 0.77% of CASI Pharmaceuticals' shares are currently sold short. Learn More on CASI Pharmaceuticals' current short interest. Which institutional investors are shorting CASI Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CASI Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for CASI Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.77% of CASI Pharmaceuticals' floating shares are currently sold short. Is CASI Pharmaceuticals' short interest increasing or decreasing? CASI Pharmaceuticals saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 30,300 shares, an increase of 131.3% from the previous total of 13,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is CASI Pharmaceuticals' float size? CASI Pharmaceuticals currently has issued a total of 12,300,000 shares. Some of CASI Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CASI Pharmaceuticals currently has a public float of 3,920,000 shares. How does CASI Pharmaceuticals' short interest compare to its competitors? 0.77% of CASI Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CASI Pharmaceuticals: PMV Pharmaceuticals, Inc. (2.14%), VistaGen Therapeutics, Inc. (6.84%), Genenta Science S.p.A. Unsponsored ADR (0.03%), Repare Therapeutics Inc. (2.05%), Anebulo Pharmaceuticals, Inc. (0.15%), Ikena Oncology, Inc. (0.43%), Context Therapeutics Inc. (2.91%), Assertio Holdings, Inc. (6.37%), Forte Biosciences, Inc. (1.38%), Sutro Biopharma, Inc. (4.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short CASI Pharmaceuticals stock? Short selling CASI is an investing strategy that aims to generate trading profit from CASI Pharmaceuticals as its price is falling. CASI shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CASI Pharmaceuticals? A short squeeze for CASI Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CASI, which in turn drives the price of the stock up even further. How often is CASI Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CASI, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies PMV Pharmaceuticals Short Squeeze VistaGen Therapeutics Short Squeeze Genenta Science Short Squeeze Repare Therapeutics Short Squeeze Anebulo Pharmaceuticals Short Squeeze Ikena Oncology Short Squeeze Context Therapeutics Short Squeeze Assertio Short Squeeze Forte Biosciences Short Squeeze Sutro Biopharma Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CASI) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CASI Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CASI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
